The approval of the COVID-19 vaccine was good news to wrap up 2020, but for people with Parkinson’s, questions and concerns regarding the shots’ safety, efficacy, and logistics abound. To help demystify the vaccine, APDA Greater St. Louis Chapter Medical Director and Head of the Movement Disorders Clinic at Washington University, Dr. Perlmutter, will answer questions related to the coronavirus vaccine and Parkinson’s disease.
Related Posts
